109 related articles for article (PubMed ID: 11247044)
1. Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs.
Salvatori D; Vincenzetti S; Maury G; Gosselin G; Gaubert G; Vita A
Comp Immunol Microbiol Infect Dis; 2001 Apr; 24(2):113-22. PubMed ID: 11247044
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents.
Thormar H; Balzarini J; Debyser Z; Witvrouw M; Desmyter J; De Clercq E
Antiviral Res; 1995 May; 27(1-2):49-57. PubMed ID: 7486958
[TBL] [Abstract][Full Text] [Related]
3. Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1.
Salvatori D; Volpini R; Vincenzetti S; Vita A; Costanzi S; Lambertucci C; Cristalli G; Vittori S
Bioorg Med Chem; 2002 Sep; 10(9):2973-80. PubMed ID: 12110319
[TBL] [Abstract][Full Text] [Related]
4. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
[TBL] [Abstract][Full Text] [Related]
6. Maedi-visna virus and its relationship to human immunodeficiency virus.
Thormar H
AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
[TBL] [Abstract][Full Text] [Related]
7. Phosphonoformate inhibition of visna virus replication.
Sundquist B; Larner E
J Virol; 1979 Jun; 30(3):847-51. PubMed ID: 90168
[TBL] [Abstract][Full Text] [Related]
8. Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
Frank KB; McKernan PA; Smith RA; Smee DF
Antimicrob Agents Chemother; 1987 Sep; 31(9):1369-74. PubMed ID: 2445282
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine on visna virus infection in lambs: a model for in vivo testing of candidate anti-human immunodeficiency virus drugs.
Thormar H; Georgsson G; Pálsson PA; Balzarini J; Naesens L; Torsteinsdóttir S; De Clercq E
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3283-7. PubMed ID: 7724553
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte macrophage colony stimulating factor is elevated in alveolar macrophages from sheep naturally infected with maedi-visna virus and stimulates maedi-visna virus replication in macrophages in vitro.
Zhang Z; Harkiss GD; Hopkins J; Woodall CJ
Clin Exp Immunol; 2002 Aug; 129(2):240-6. PubMed ID: 12165079
[TBL] [Abstract][Full Text] [Related]
11. Cellular specificity and replication rate of Maedi Visna virus in vitro can be controlled by LTR sequences.
Barros SC; Andrésdóttir V; Fevereiro M
Arch Virol; 2005 Feb; 150(2):201-13. PubMed ID: 15614437
[TBL] [Abstract][Full Text] [Related]
12. The origin of lentivirus research: Maedi-visna virus.
Thormar H
Curr HIV Res; 2013 Jan; 11(1):2-9. PubMed ID: 23278353
[TBL] [Abstract][Full Text] [Related]
13. Human and ovine lentiviral infections compared.
Pétursson G; Andrésdóttir V; Andrésson O; Torsteinsdóttir S; Georgsson G; Pálsson PA
Comp Immunol Microbiol Infect Dis; 1991; 14(4):277-87. PubMed ID: 1684142
[TBL] [Abstract][Full Text] [Related]
14. Restrictive type of replication of ovine/caprine lentiviruses in ovine fibroblast cell cultures.
Chebloune Y; Sheffer D; Karr BM; Stephens E; Narayan O
Virology; 1996 Aug; 222(1):21-30. PubMed ID: 8806484
[TBL] [Abstract][Full Text] [Related]
15. Genomic characterization of a slow/low maedi visna virus.
Barros SC; Ramos F; Duarte M; Fagulha T; Cruz B; Fevereiro M
Virus Genes; 2004 Oct; 29(2):199-210. PubMed ID: 15284480
[TBL] [Abstract][Full Text] [Related]
16. Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus.
Andrésdóttir V; Tang X; Agnarsdóttir G; Andrésson OS; Georgsson G; Skraban R; Torsteinsdóttir S; Rafnar B; Benediktsdóttir E; Matthíasdóttir S; Arnadóttir S; Högnadóttir S; Pálsson PA; Pétursson G
Virus Genes; 1998; 16(3):281-93. PubMed ID: 9654682
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human alpha A interferon on Visna virus multiplication in acutely infected ovine cells.
Canivet M; Hurpin C; Rozain F; Tanaka A; Lasneret J; Debons-Guillemin MC; Périès J
J Biol Regul Homeost Agents; 1989; 3(3):122-7. PubMed ID: 2560315
[TBL] [Abstract][Full Text] [Related]
18. Visna virus-induced cytopathic effect in vitro is caused by apoptosis.
Duval R; Delebassée S; Cardot PJ; Bosgiraud C
Arch Virol; 2002 May; 147(5):943-59. PubMed ID: 12021866
[TBL] [Abstract][Full Text] [Related]
19. Deaza- and deoxyadenosine derivatives: synthesis and inhibition of animal viruses as human infection models.
Vittori S; Salvatori D; Volpini R; Vincenzetti S; Vita A; Taffi S; Costanzi S; Lambertucci C; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):877-81. PubMed ID: 14565301
[TBL] [Abstract][Full Text] [Related]
20. The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro.
Kristbjörnsdóttir HB; Andrésdóttir V; Svansson V; Torsteinsdóttir S; Matthíasdóttir S; Andrésson OS
Virology; 2004 Jan; 318(1):350-9. PubMed ID: 14972560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
